Evidence map›Paper›PMID 42144336›Full record

ArticleEndocrine journal2026

From cross-section to prognosis: risk factors for renal function deterioration in primary hyperparathyroidism.

Takuma Yamoto, Masakazu Notsu, Keizo Kanasaki

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Endocrine journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Takuma YamotoDepartment of Internal Medicine 1, Shimane University Faculty of Medicine, Shimane 693-8501, Japan.
Masakazu NotsuDepartment of Internal Medicine 1, Shimane University Faculty of Medicine, Shimane 693-8501, Japan.ORCID http://orcid.org/0000-0002-8326-8154
Keizo KanasakiDepartment of Internal Medicine 1, Shimane University Faculty of Medicine, Shimane 693-8501, Japan.ORCID http://orcid.org/0000-0002-9563-502X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Renal dysfunction is an important complication of primary hyperparathyroidism (pHPT). However, the factors associated with a decline in estimated glomerular filtration rate (eGFR) in patients with pHPT have not been fully investigated. This study aimed to identify the factors associated with reduced eGFR at diagnosis in patients with pHPT, and the determinants of longitudinal eGFR decline among those with follow-up data. Eighty-nine patients with pHPT were categorized by renal function at diagnosis. In addition, the annual eGFR decline rate was assessed in 47 patients with more than one year of follow-up. Clinical and biochemical variables were analyzed to determine their association with renal function. Compared with the normal renal function group, the reduced renal function group (eGFR <60 mL/min/1.73 m

Indexed as

Glomerular Filtration RateHyperparathyroidism, PrimaryKidneyAgedCalciumCross-Sectional StudiesDisease ProgressionFemaleHumansMaleMiddle AgedPhosphatesPrognosisRisk FactorsVitamin D25-hydroxyvitamin DCalciumPhosphatesVitamin DChlorideDecreased renal functionParathyroid hormonePrimary hyperparathyroidismTubular reabsorption of phosphate

Identifiers

PMID42144336
PMCPMC13478687

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.